Search
Showing results for "aboriginal respiratory"
Research
Pediatric hospital admissions in Indigenous children: A population-based study in remote AustraliaWe analysed hospital admissions of a predominantly Aboriginal cohort of children in the remote Fitzroy Valley in Western Australia during their first 7 years.
Research
Association between early bacterial carriage and otitis media in Aboriginal and non-Aboriginal childrenStreptococcus pneumoniae (Pnc), nontypeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis (Mcat) are the most important bacterial pathogens...
Research
Infant respiratory infections and later respiratory hospitalisation in childhoodThe aim of this study was to use total-population based data on an otherwise healthy population of children to assess the relationship between early...
Research
Preventing perioperative respiratory complications in children with recurrent respiratory symptomsElizabeth Graham Smith Hall PhD, MSc, BSc BAppSci PhD CRFS FANZSRS FThorSoc FERS Program Manager Honorary Research Associate 08 6319 1178
News & Events
Wal-yan Centre inaugural Shark Tank winnersCongratulations to Dr Montgomery, Dr Iosifidis and Dr D’Vaz on winning the Wal-yan Centre's inaugural seed funding competition.
Research
Moort Vax Waangkiny: Understanding reasons for routine vaccine uptake among Aboriginal children aged <5 years in Perth (Boorloo) metroAboriginal children aged younger than 5 years in Perth (Boorloo) have lower vaccine uptake compared to non-Aboriginal children.
casual research assistant kimberley
Research
Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort studyAboriginal children are at greater risk of rotavirus disease than non-Aboriginal children and delayed vaccine receipt is substantially higher
Research
The clinical utility of lung clearance index in early cystic fibrosis lung disease is not impacted by the number of multiple-breath washout trialsThis study aimed to determine if relationships between LCI and clinical outcomes of CF lung disease differ when only two acceptable MBW trials are assessed.